194 related articles for article (PubMed ID: 20606468)
21. Scaling in vitro activity of CYP3A7 suggests human fetal livers do not clear retinoic acid entering from maternal circulation.
Topletz AR; Zhong G; Isoherranen N
Sci Rep; 2019 Mar; 9(1):4620. PubMed ID: 30874620
[TBL] [Abstract][Full Text] [Related]
22. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells.
Lampen A; Meyer S; Nau H
Biochim Biophys Acta; 2001 Oct; 1521(1-3):97-106. PubMed ID: 11690641
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the roles of peroxisome proliferator-activated receptor and retinoic acid receptor on CYP26 regulation.
Tay S; Dickmann L; Dixit V; Isoherranen N
Mol Pharmacol; 2010 Feb; 77(2):218-27. PubMed ID: 19884280
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid 4-hydroxylase-mediated catabolism of all-trans retinoic acid and the cell proliferation in head and neck squamous cell carcinoma.
Kim SY; Yoo SJ; Kwon HJ; Kim SH; Byun Y; Lee KS
Metabolism; 2002 Apr; 51(4):477-81. PubMed ID: 11912557
[TBL] [Abstract][Full Text] [Related]
25. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
McCaffery P; Simons C
Curr Pharm Des; 2007; 13(29):3020-37. PubMed ID: 17979744
[TBL] [Abstract][Full Text] [Related]
26. A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis.
Krivospitskaya O; Elmabsout AA; Sundman E; Söderström LA; Ovchinnikova O; Gidlöf AC; Scherbak N; Norata GD; Samnegård A; Törmä H; Abdel-Halim SM; Jansson JH; Eriksson P; Sirsjö A; Olofsson PS
Mol Med; 2012 May; 18(1):712-8. PubMed ID: 22415012
[TBL] [Abstract][Full Text] [Related]
27. Homology models of human all-trans retinoic acid metabolizing enzymes CYP26B1 and CYP26B1 spliced variant.
Saenz-Méndez P; Elmabsout AA; Sävenstrand H; Awadalla MK; Strid Å; Sirsjö A; Eriksson LA
J Chem Inf Model; 2012 Oct; 52(10):2631-7. PubMed ID: 22985482
[TBL] [Abstract][Full Text] [Related]
28. Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.
Isoherranen N; Zhong G
Pharmacol Ther; 2019 Dec; 204():107400. PubMed ID: 31419517
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo.
Zolfaghari R; Cifelli CJ; Lieu SO; Chen Q; Li NQ; Ross AC
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1029-36. PubMed ID: 17185629
[TBL] [Abstract][Full Text] [Related]
30. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
[TBL] [Abstract][Full Text] [Related]
31. Differences in retinol metabolism and proliferative response between neointimal and medial smooth muscle cells.
Gidlof AC; Ocaya P; Olofsson PS; Torma H; Sirsjo A
J Vasc Res; 2006; 43(4):392-8. PubMed ID: 16837774
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases.
Kosaka C; Sasaguri T; Komiyama Y; Takahashi H
Hypertens Res; 2001 Sep; 24(5):579-88. PubMed ID: 11675954
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling reveals Cyp26b1 to be an activin regulated gene involved in ovarian granulosa cell proliferation.
Kipp JL; Golebiowski A; Rodriguez G; Demczuk M; Kilen SM; Mayo KE
Endocrinology; 2011 Jan; 152(1):303-12. PubMed ID: 21084447
[TBL] [Abstract][Full Text] [Related]
34. Cardiac retinoic acid levels decline in heart failure.
Yang N; Parker LE; Yu J; Jones JW; Liu T; Papanicolaou KN; Talbot CC; Margulies KB; O'Rourke B; Kane MA; Foster DB
JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33724958
[TBL] [Abstract][Full Text] [Related]
35. Restriction of retinoic acid activity by Cyp26b1 is required for proper timing and patterning of osteogenesis during zebrafish development.
Laue K; Jänicke M; Plaster N; Sonntag C; Hammerschmidt M
Development; 2008 Nov; 135(22):3775-87. PubMed ID: 18927157
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.
Quere R; Baudet A; Cassinat B; Bertrand G; Marti J; Manchon L; Piquemal D; Chomienne C; Commes T
Blood; 2007 May; 109(10):4450-60. PubMed ID: 17218384
[TBL] [Abstract][Full Text] [Related]
37. Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.
Diaz P; Huang W; Keyari CM; Buttrick B; Price L; Guilloteau N; Tripathy S; Sperandio VG; Fronczek FR; Astruc-Diaz F; Isoherranen N
J Med Chem; 2016 Mar; 59(6):2579-95. PubMed ID: 26918322
[TBL] [Abstract][Full Text] [Related]
38. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT
Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180
[TBL] [Abstract][Full Text] [Related]
39. Induction of the cytochrome P450 gene CYP26 during mucous cell differentiation of normal human tracheobronchial epithelial cells.
Kim SY; Adachi H; Koo JS; Jetten AM
Mol Pharmacol; 2000 Sep; 58(3):483-90. PubMed ID: 10953040
[TBL] [Abstract][Full Text] [Related]
40. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
